Cutia Therapeutics is a public biotech or pharmaceutical company listed on HKEX under the ticker 2487, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Cutia Therapeutics news
We have not published a story on Cutia Therapeutics yet. When there is news, it will appear here.
Questions about Cutia Therapeutics
What is the ticker symbol of Cutia Therapeutics?
Cutia Therapeutics trades under the ticker 2487 on HKEX.
Where is Cutia Therapeutics listed?
Cutia Therapeutics is listed on HKEX.
Which country or territory is Cutia Therapeutics listed under?
Our directory records Cutia Therapeutics under China.
What does Cutia Therapeutics do?
Our directory classifies Cutia Therapeutics as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Cutia Therapeutics?
The ISIN recorded for Cutia Therapeutics is KYG2606C1006.
Does aibio.space cover Cutia Therapeutics?
aibio.space lists Cutia Therapeutics among 2,820 public biotech companies and publishes its news here as stories appear.
Which companies are similar to Cutia Therapeutics?
Companies in our directory listed in the same country and business area as Cutia Therapeutics: Beijing Centergate Technologies (Holding) Co., Guizhou Bailing Group Pharmaceutical Co., Shanghai Henlius Biotech, Youcare Pharmaceutical Group Co., Zhejiang Jingxin Pharmaceutical Co., PKU Healthcare Corp..
Investor discussion: Cutia Therapeutics
Members talk about Cutia Therapeutics (2487). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Capital-markets timeline
Financings, listing notices, splits, legal actions and other investor events at Cutia Therapeutics, newest first. Each line links the filing it comes from.
Financings
Share or debt issue: COMPLETION OF PLACING OF NEW SHARES
UNDER GENERAL MANDATE. Source
Financings
Share or debt issue: PLACING OF NEW SHARES UNDER GENERAL MANDATE. Source
Press releases
Headlines of Cutia Therapeutics's own announcements, newest first. Each opens the full release on the newswire that carried it.
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:2487 on TradingView.
Listing details
Cutia Therapeutics is a public biotech or pharmaceutical company listed on HKEX under the ticker 2487, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio